Which statement best describes the relationship between a biosimilar and a biologic drug?

• A. A biosimilar is legally identical to the original biologic.
• B. A biologic is a small-molecule chemical.
• C. A biosimilar is completely different in structure from the original.
• D. A biosimilar is highly similar but not identical to an authorized biologic drug.

Answer: (D)

A biosimilar is designed to be highly similar to an existing biologic reference product, but because biologics are large, complex proteins produced in living systems, an exact copy cannot be guaranteed. This is why the correct statement is that a biosimilar is highly similar but not identical to an authorized biologic drug. Regulators require rigorous analyses to show there are no clinically meaningful differences in safety, purity, and potency, with any minor differences not affecting clinical outcomes. The reference product remains the standard for comparison, and while biosimilars aim to match its therapeutic effect and mechanism of action, tiny variations in structure can occur, unlike small-molecule drugs which can be exact copies.